Gastrointestinal News on in vitro diagnostics for gastrointestinal disease. Castle Biosciences Buy of Cernostics Aligns With Goal to Diversify Portfolio Premium The acquisition of Cernostics and its TissueCypher Barrett's Esophagus Assay provides a route for Castle to enter gastrointestinal testing. Genetic Analysis Raises $6.8M in Oversubscribed IPO The Norwegian microbiome diagnostic company's stock closed up 50 percent after two days of trading on the Swedish Spotlight Stock Market. Norway's Genetic Analysis Hopes HumGut Database Will Spawn New Diagnostics, Therapies Premium In particular, the diagnostics company expects the new resource to strengthen its offerings to pharmaceutical partners, a key customer group. Lucid Diagnostics Obtains CE Mark for Esophageal Cancer Molecular Test Lucid said that key opinion leaders for esophageal disease in Europe are participating in pivotal clinical trials for the test and its collection device. Adaptive Biotech Touts Progress Toward Lyme and Gastrointestinal Disease Diagnostics Premium The firm is expanding its plans from a Crohn's disease test to a broader GI differential diagnostic and continues to expect to launch its Lyme disease assay by year-end. Mar 12, 2021 Prometheus Biosciences Prices Upsized $190M IPO Jan 19, 2021 ABO Histo-Blood Groups Influence Makeup of Gut Microbiome, New Study Finds Dec 8, 2020 Single-Cell Transcriptome Study Links Gut Development, Pediatric Crohn's Disease Sep 2, 2020 BiomX, Boehringer Ingelheim Partner for Inflammatory Bowel Disease Biomarker Discovery Aug 12, 2020 Traveler's Diarrhea Among Soldiers Linked to Gut Microbiome Changes Jul 10, 2020 Infant Gut Microbiome Correlates With Bacteria in Mother's Breast Milk, Study Finds Jun 19, 2020 Progenity Prices $100M IPO at $15 per Share Mar 5, 2020 Genedata Moves Into R&D for Nonprofits, Adds Digital Pathology Support Premium Nov 7, 2019 PredictImmune, Crohn's & Colitis Foundation Collaborate on IBD Test Validation Study Oct 28, 2019 Theradiag to Commercialize PredictImmune IBD Test in French-Speaking Europe and Africa Sep 4, 2019 uBiome Declares Bankruptcy, Offers Assets for Sale Jun 18, 2019 Mayo Clinic Spinout Developing Multiomics Blood Test to Identify Obesity Phenotypes Premium Apr 19, 2019 Active Celiac Disease Processes Informed by Intestinal Expression Comparison Apr 18, 2019 Pancreatic, Brain Development Gene Found From Patient Exomes Apr 11, 2019 Hirschsprung's Disease Genetic Analysis Reveals Mix of Common, Rare Risk Variants Mar 6, 2019 Inflammatory Bowel Disease Transcriptome Analysis Finds Increased Levels of SERPINE1 Feb 26, 2019 New IBD Adverse Drug Response Risk Gene Identified Feb 19, 2019 Australia's Microba Taps Google Cloud for Human Gut Microbiome Data Processing Premium Feb 4, 2019 Gut Microbe Studies Expand Bacterial Culture Collections, Reference Genomes Jan 24, 2019 Meridian Fiscal Q1 Revenues Down 2 Percent Load More Breaking News Danaher Prices $1B Offering of Senior Notes Discovery Life Sciences Acquires Contract Research Firm In Vitro ADMET Laboratories Audere Gets FDA Emergency Use Authorization for SARS-CoV-2 At-Home Sample Collection Kit GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy Metabolomic Study Links 13 Metabolites to Coronary Heart Disease Risk Among African Americans The Scan Panel Votes for COVID-19 Pill A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says. But Not Harm New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare. Effectiveness Drop Anticipated Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports. Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.